fda glp-1 compounding crackdown october 2025 Why the is cracking down on compound drugs for weight loss Pharmacovigilance Assessment of Compounded GLP-1
Description
Going back today
GLP-1 agonists work best when combined with healthy lifestyle changes, including diet and exercise
If it goes unnoticed or neglected, the medication can be ruined
Our data shows a concerning rise in non-compliant advertising and the sale of these medications without a prescription, putting consumers at a great risk
Medicare does not currently cover GLP1s for obesity, but recently announced that they will be among the drug classes which the federal government will aim to negotiate in 2025
